Risk stratification in critically ill patients: GDF-15 scores in adult respiratory distress syndrome

Critical Care

Volumn 17, Issue 4, 2013, Pages

  Kempf, Tibor ^a   Wollert, Kai C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GROWTH DIFFERENTIATION FACTOR 15; PROTEIN P53;

ADULT RESPIRATORY DISTRESS SYNDROME; APACHE; AREA UNDER THE CURVE; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; CRITICALLY ILL PATIENT; DISEASE COURSE; DISEASE SEVERITY; HEART FAILURE; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; LUNG EMBOLISM; MORTALITY; NOTE; OXIDATIVE STRESS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; BLOOD; FEMALE; MALE;

FEMALE; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; MALE; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84881248165     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12765     Document Type: Note

References (9)

1. Clark BJ, Bull TM, Benson AB, Stream AR, Macht M, Gaydos J, Meadows C, Burnham EL, Moss M. Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort study. Crit Care 2013, 17:R92. 10.1186/cc12737, 23706007.
2. Pencina MJ, D'Agostino RB, Pencina KM, Janssens AC, Greenland P. Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol 2012, 176:473-481. 10.1093/aje/kws207, 22875755.
3. Wollert KC, Kempf T, Peter T, Olofsson S, James S, Johnston N, Lindahl B, Horn-Wichmann R, Brabant G, Simoons ML, Armstrong PW, Califf RM, Drexler H, Wallentin L. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation 2007, 115:962-971. 10.1161/CIRCULATIONAHA.106.650846, 17283261.
4. Lankeit M, Kempf T, Dellas C, Cuny M, Tapken H, Peter T, Olschewski M, Konstantinides S, Wollert KC. Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism. Am J Respir Crit Care Med 2008, 177:1018-1025. 10.1164/rccm.200712-1786OC, 18263797.
5. Worthmann H, Kempf T, Widera C, Tryc AB, Goldbecker A, Ma YT, Deb M, Tountopoulou A, Lambrecht J, Heeren M, Lichtinghagen R, Wollert KC, Weissenborn K. Growth differentiation factor 15 plasma levels and outcome after ischemic stroke. Cerebrovasc Dis 2011, 32:72-78. 10.1159/000328233, 21613788.
6. Nickel N, Kempf T, Tapken H, Tongers J, Laenger F, Lehmann U, Golpon H, Olsson K, Wilkins MR, Gibbs JS, Hoeper MM, Wollert KC. Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2008, 178:534-541. 10.1164/rccm.200802-235OC, 18565955.
7. Kempf T, Sinning JM, Quint A, Bickel C, Sinning C, Wild PS, Schnabel R, Lubos E, Rupprecht HJ, Münzel T, Drexler H, Blankenberg S, Wollert KC. Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study. Circ Cardiovasc Genet 2009, 2:286-292. 10.1161/CIRCGENETICS.108.824870, 20031597.
8. Anand IS, Kempf T, Rector TS, Tapken H, Allhoff T, Jantzen F, Kuskowski M, Cohn JN, Drexler H, Wollert KC. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial. Circulation 2010, 122:1387-1395. 10.1161/CIRCULATIONAHA.109.928846, 20855664.
9. Lok SI, Winkens B, Goldschmeding R, van Geffen AJ, Nous FM, van Kuik J, van der Weide P, Klöpping C, Kirkels JH, Lahpor JR, Doevendans PA, de Jonge N, de Weger RA. Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support. Eur J Heart Fail 2012, 14:1249-1256. 10.1093/eurjhf/hfs120, 22843564.